UBS Reiterates Buy on Meta, $715 PT

Aug 27, 2026· Analyst: Stephen Ju· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$715
Previous
Implied upside
+24%

UBS analyst Stephen Ju reiterated a Buy rating and $715 price target on Meta Platforms Inc. (NASDAQ: META).

“Meta announced on Wednesday that it had agreed to pay up to $18B and make app changes for teen / underage accounts to settle a lawsuit, brought on by a coalition of 29 US states, that had alleged that the company targeted and harmed young users.

We view this as the removal of a key overhang on the stock. The fine amount itself is a less punitive outcome vs the oft-repeated Big Tobacco analogy for $200B in fines.

More importantly, long-term product changes also seem more benign to us vs potentially structural changes that could have limited Meta’s ability to serve targeted ads.

We also point to Meta’s call for direct social media rivals YouTube and TikTok to adopt the product changes – which we think could come to bear given public scrutiny – and if so could neutralize any disadvantage Meta has in capturing engagement share.

We reiterate our Buy on Meta and continue to believe that EPS is likely to move up from here given multiple avenues to achieve better-than-consensus revenue growth (ramp in monetization of Business Agents or external sale of excess compute capacity).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.